Beruflich Dokumente
Kultur Dokumente
************************************************************************
************************************************************************
<Name of molecule>
N-Phenylanthranilic acid,2',3'-dimethyl
<Molecular formula>
C15 H15 N O2
<Molecular weight>
241.2896
5.120
<Reference>
LA ROTONDA,M.,SILIPO,C.,ET.AL.,QUANT.STRUCT.ACT.RELAT.,2,168(1983)
AT PH = 2.0
2.000
<Reference>
LA ROTONDA,M.,SILIPO,C.,ET.AL.,QUANT.STRUCT.ACT.RELAT.,2,168(1983)
PH= 7.4, PHOSPHATE BUFFER; NOT ION-CORRECTED
2.370
<Reference>
TERADA,H.,MURAOKA,S.,FUJITA,T.,J.MED.CHEM.,17,330(1974)
2.050
<Reference>
MENASSE,R.,ET.AL.,SCAND.J.RHEUMAT.,SUPPL.22,5(1978)
4.300
<Reference>
LA ROTONDA,M.,SILIPO,C.,ET.AL.,QUANT.STRUCT.ACT.RELAT.,2,168(1983)
PH = 4.50
5.370
<Reference>
TERADA,H.,MURAOKA,S.,FUJITA,T.,J.MED.CHEM.,17,330(1974)
<pKa>
4.200
<Reference>
LA ROTONDA,M.,SILIPO,C.,ET.AL.,QUANT.STRUCT.ACT.RELAT.,2,168(1983)
PH = 4.50
5.800
<Reference>
TERADA,H.,MURAOKA,S.,MOL.PHARMACOL.,8,95(1971)
4.330
<Reference>
TERADA,H.,MURAOKA,S.,FUJITA,T.,J.MED.CHEM.,17,330(1974)
4.200
<Reference>
LA ROTONDA,M.,SILIPO,C.,ET.AL.,QUANT.STRUCT.ACT.RELAT.,2,168(1983)
AT PH = 2.0
4.200
<Reference>
MENASSE,R.,ET.AL.,SCAND.J.RHEUMAT.,SUPPL.22,5(1978)
4.200
<Reference>
LA ROTONDA,M.,SILIPO,C.,ET.AL.,QUANT.STRUCT.ACT.RELAT.,2,168(1983)
************************************************************************
************************************************************************
Log(p)........: 4.03
St..deviation.: 0.47
Log(p)........: 3.93
St..deviation.: 0.49
Log(p)........: 3.65
St..deviation.: 0.55
************************************************************************
************************************************************************
St..deviation.: 1.27
St..deviation.: 0.77
************************************************************************
************************************************************************
************************************************************************
************************************************************************
************************************************************************
************************************************************************
************************************************************************
************************************************************************